SEC Form 4 · accession 0000899243-18-009562
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Sjogren
Officer — SR. VP, DRUG DISCOVERY
Period of report
Apr 3, 2018
Accepted (ET)
Apr 5, 2018 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 3, 2018 | M | 16,810 | $0.48 | A | 42,818 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $0.48 | Apr 3, 2018 | M | 8,209 | D | — | Dec 13, 2021 | Common Stock | 8,209 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $0.48 | Apr 3, 2018 | M | 8,601 | D | — | Jun 12, 2022 | Common Stock | 8,601 | 0 | D |
Explanation of responses
- F1Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan each on May 15, 2015, November 13, 2015, May 13, 2016, June 9, 2017 and December 8, 2017. Includes 1,877 shares acquired under the Company's 2014 Employee Stock Purchase Plan on November 15, 2016.
- F21/48 of the Option vests in equal monthly installments one month from 11/07/2011.
- F31/48 of the Option vests in equal monthly installments one month from 03/27/2012.